- Home
- FLOC vs ARQT Comparison
FLOC vs ARQT Comparison
Compare FLOC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOC
- ARQT
- Stock Information
- Founded
- FLOC 1996
- ARQT 2016
- Country
- FLOC United States
- ARQT United States
- Employees
- FLOC N/A
- ARQT N/A
- Industry
- FLOC Metal Fabrications
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- FLOC Industrials
- ARQT Health Care
- Exchange
- FLOC Nasdaq
- ARQT Nasdaq
- Market Cap
- FLOC 1.9B
- ARQT 1.7B
- IPO Year
- FLOC 2025
- ARQT 2020
- Fundamental
- Price
- FLOC $17.44
- ARQT $13.82
- Analyst Decision
- FLOC Strong Buy
- ARQT Strong Buy
- Analyst Count
- FLOC 5
- ARQT 6
- Target Price
- FLOC $33.40
- ARQT $18.80
- AVG Volume (30 Days)
- FLOC 402.7K
- ARQT 1.9M
- Earning Date
- FLOC 08-06-2025
- ARQT 08-13-2025
- Dividend Yield
- FLOC 0.46%
- ARQT N/A
- EPS Growth
- FLOC N/A
- ARQT N/A
- EPS
- FLOC 2.69
- ARQT N/A
- Revenue
- FLOC $660,916,000.00
- ARQT $212,819,000.00
- Revenue This Year
- FLOC $51.92
- ARQT $61.15
- Revenue Next Year
- FLOC $11.23
- ARQT $37.98
- P/E Ratio
- FLOC $6.51
- ARQT N/A
- Revenue Growth
- FLOC 156.58
- ARQT 100.03
- 52 Week Low
- FLOC $15.83
- ARQT $7.86
- 52 Week High
- FLOC $30.50
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- FLOC N/A
- ARQT 50.73
- Support Level
- FLOC N/A
- ARQT $12.97
- Resistance Level
- FLOC N/A
- ARQT $13.84
- Average True Range (ATR)
- FLOC 0.00
- ARQT 0.61
- MACD
- FLOC 0.00
- ARQT 0.02
- Stochastic Oscillator
- FLOC 0.00
- ARQT 51.64
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.